Abstract: The invention relates to a pharmaceutical composition comprising a glucuronate, glucoside, and/or sulfo conjugate of 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one, or such a conjugate of a derivative of 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one, or a physiologically well tolerated salt of such a conjugate.

Abstract: This invention relates to pharmaceutically active compounds consisting of an isoflavone or isoflavone-glycoside and an amino acid, a peptide or peptide derivate with 2 to 5 amino acids which is covalently bonded to these, as well as pharmaceutically acceptable salts or solvates of these compositions as well as to the use of those substances for the production of pharmaceutical compositions, in particular for the treatment of thrombocyte aggregation and tumor therapy. Consequently, the areas of application of the invention are medicine and the pharmaceutical industry. The compounds according to the invention have the general formula (I). X-Pep??(I) whereupon X is an isoflavone or isoflavone-glycoside, and Pep is an amino acid or a peptide or peptide derivate with 2 to 5 amino acids, and there is a bond between X and Pep either with a covalent bond or with a linker system.

Abstract: The invention relates to a device and a method for separating substances by liquid chromatography. The aim of the invention is to provide a device and a method by which means substances can be separated by liquid chromatography under pressure and which enable parallel separation and detection of at least several samples. The device should have a compact, economical construction. To this end, the inventive device for separating substances by liquid chromatography under pressure is characterized in that at least several liquid chromatography separating lines (17) are supplied by a single delivery unit (one or two pumps), said separating lines being arranged so that they run parallel, and in that said separating lines are combined with a sample-loading system (5) and an injection system (18) in the sample introduction area and with a multi-channel detector (13), connected to an evaluation and control unit (16), in the detection area.

Abstract: The invention relates a method and a device for regulating individual sub-flows of a conveying system while the main flow is conveyed in a constant manner. The aim of the invention is to provide a method and a device which enable the sub-flows of the conveying lines of a system for conveying fluid media to be regulated as required in said individual conveying lines with just one conveyor unit. To this end, the inventive device for regulating individual sub-flows of a system for conveying fluid media has several conveying lines which are guided in parallel. The invention is characterized in that the following are arranged in the conveying system: at least one total pressure measuring device (10), at least one sub-flow measuring unit (D) in each conveying line, at least one valve (7) with a throttle (B) and a data acquisition, processing and control value output module (C), these being functionally interconnected by hardware and/or software.

Abstract: Use of (S,S)-N,N'-ethylenediamine disuccinate (EDDS) of formula I wherein M.dbd.H.sup.+ and/or any pharmaceutically acceptable cation, for the preparation of a medicament for the treatment of cytomegaloviral infections which has immunosuppressive properties.

Abstract: The invention concerns an HPLC-based device and method for separating high complex substance mixtures. Plant and microbial extracts are high complex substance mixtures. They contain large amounts of extremely polar and non-polar materials. In principle, said mixtures can be separated by using a chromatic method. However, separation with existing chromatographic devices, for instance HPLC installations, is extremely time-consuming. The invention seeks to create a HPLC installation that separates fully automatically high complex substances in a very short time in such a way that said substances are broken down into their components in an almost pure state and can then be fed into a test system. To this end, said HPLC-based device comprises separation column units (A, F),fractionating column units (E, G), detector units (7, and 20, 21), pumping units (B, C, D) and fraction collecting units.

Abstract: The invention relates to novel .gamma.-pyrones, .gamma.-pyridones and .gamma.-thiopyrones and their use as medicaments against viral diseases, preferably for the treatment of retroviral diseases, comprising compounds of the formula (I), in which R.sub.1 and R.sub.2 stand for hydrogen, a branched-chain or unbranched-chain C.sub.1 to C.sub.26, preferably C.sub.1 to C.sub.6 alkyl, C.sub.1 to C.sub.26 alkenyl or C.sub.1 to C.sub.26 alkinyl group or combinations thereof; R.sub.3 stands for a branched-chain or unbranched-chain C.sub.1 to C.sub.26 alkyl group; and R.sub.4 stands for a C.sub.3 to C.sub.26 cycloalkyl, branched-chain or unbranched-chain alkyl, alkenyl or alkinyl group. The hydrogen atoms of the methylenic group in R.sub.1, R.sub.2 and R.sub.4 may be substituted by O alkyl (C.sub.1 to C.sub.6), O acyl, O aryl, O aralkyl and alkyl (C.sub.1 to C.sub.6) groups, and in R.sub.4 also by halogenated groups, oxo groups and hydroxylic groups with double links.